Market pulse › CDMO
Today1 story · 1 articles
Net tone▲ +100% today
Market checkAlkem Laboratories −1.0%
Developing0 storylines
125 Sept
126 Sept
027 Sept
128 Sept
Broker call▲ bullishDr Reddy's shares gain over 1% after Nomura retains 'Buy'; Rs1,740 target, key biologics milestones aheadDr Reddy'sPharma and healthcare
Broker call● mixedAlkem Labs: Hold on till growth gets a new boostCDMO and medtech segments are expected to supplement Alkem’s base-business growth over the long termAlkem LaboratoriesSN Genelab
Expansion▲ bullishBiocon Malaysia facility wins UK approval for Semglee fill-finish operationsUK MHRA approval covers Biocon’s Malaysia-based insulin fill-finish line for SemgleeBioconPharma and healthcareUnited Kingdom